Bharat Biotech said iNCOVACC is world’s first intranasal vaccine to get approval from Central Drugs Standard Control Organisation for use as heterologous booster doses in India.
A press release from Corbevax maker said it could be administered as a booster after six months of administration of primary vaccination for restricted use in emergency situation.
Non-peer-reviewed study by Hyderabad’s AIG Hospitals & Asian Health Foundation focuses on these 30%. AIG head says 70% who retain antibodies can benefit from booster after 9 months.
Vaccine hesitancy and surging infections among healthcare workers believed to be likely reasons for fall in booster demand. Numbers fluctuating for frontline workers & senior citizens.
With senior citizens and frontline workers getting the third dose of vaccines, ThePrint explains when they are needed, and what booster shots do to bolster the immune system.
Report looks at imbalance between equity & corporate bond markets amid India’s growth ambitions and diverse capital needs, while outlining strategy to unlock full potential.
Of the total package, $649 million will be utilised for additional hardware, software, and support services, and the remaining for Major Defence Equipment (MDE).
None of Pakistan’s PMs has lasted 5 years. That the current PM has given Asim Munir 5 years shows that of all military dictatorships history has seen, Pakistan’s is most creative.
COMMENTS